Research Topics
| Patrick CheungSummaryAffiliation: Sunnybrook and Women's College Health Sciences Centre Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancerPatrick Cheung
Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 62:418-25. 2005..Conclusions: PTV margins can be reduced significantly with daily online correction of prostate position. Delivering a hypofractionated boost with this high-precision IMRT technique resulted in acceptable acute toxicity...- Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomyAndrew Pearce
Department of Radiation Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada
Int J Radiat Oncol Biol Phys 65:78-83. 2006..CONCLUSION: The combined treatment with salvage RT plus 2-year AS had relatively minor long-term effects on QOL... - Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?Gerard Morton
Sunnybrook Odette Cancer Centre, Toronto, Canada
Radiother Oncol 100:463-7. 2011..Our purpose is to compare outcomes with a single fraction HDR boost to that with a standard fractionated boost in intermediate risk prostate cancer... - Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancerGerard C Morton
Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, ON, Canada
Int J Radiat Oncol Biol Phys 80:1299-305. 2011..To investigate the change in health-related quality of life for men after high-dose-rate brachytherapy and external beam radiotherapy for prostate cancer and the factors associated with this change... - Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgerySarat Chander
Department of Radiation Oncology, Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, ON, Canada
Int J Radiat Oncol Biol Phys 62:719-24. 2005..CONCLUSION: Two-year AS resulted in a statistically significant drop in the mean Hb, but had no clinically apparent adverse effect. The pattern of Hb change was similar to that of testosterone change... - Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of lifeGerard C Morton
Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, Canada
Int J Radiat Oncol Biol Phys 77:811-7. 2010..To determine the short- and medium-term effects of a single high-dose-rate brachytherapy fraction of 15 Gy and hypofractionated external beam radiation therapy for prostate cancer... - Testosterone recovery after prolonged androgen suppression in patients with prostate cancerFrederick H Yoon
Department of Radiation Oncology, Odette Cancer Centre at the Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
J Urol 180:1438-43; discussion 1443-4. 2008..We prospectively examined the extent and timing of testosterone recovery in patients with prostate cancer treated with 2 years of androgen suppression... - A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiothSten Myrehaug
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 82:e657-62. 2012..To perform a comparison of two pelvic lymph node volume delineation strategies used in intensity-modulated radiotherapy (IMRT) for high risk prostate cancer and to determine the role of volumetric modulated arc therapy (VMAT)... - Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancerMelanie T M Davidson
Department of Medical Physics, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Int J Radiat Oncol Biol Phys 80:1550-8. 2011..To quantify differences in treatment delivery efficiency and dosimetry between step-and-shoot intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), and helical tomotherapy (HT) for prostate treatment... - Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapyPerakaa Sethukavalan
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Can J Urol 19:6165-9. 2012..To estimate the out-of-pocket costs for patients undergoing external beam radiotherapy (EBRT) for prostate cancer and calculate the patient-related savings of being treated with a 5-fraction versus a standard 39-fraction approach... - How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?Richard Choo
Department of Radiation Oncology, Toronto Sunnybrook Regional Cancer Centre, University of Toronto, Toronto, Ontario, Canada
Can J Urol 12:2547-52. 2005..To examine the change of hemoglobin in relation to testosterone level in non-metastatic prostate cancer patients receiving 2-year androgen suppression... - External beam irradiation for localized prostate cancer--the promise of hypofractionationD Andrew Loblaw
Department of Radiation Oncology, University of Toronto, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
Can J Urol 13:62-6. 2006..In summary, hypofractionated radiation coupled with high-precision techniques may allow for better prostate cancer control rates, shorter treatment times and less toxicity... - Accelerated hypofractionated radiotherapy for early-stage non-small-cell lung cancer: long-term resultsHany Soliman
Department of Radiation Oncology, Sunnybrook Health Sciences Centre and Faculty of Medicine, University of Toronto, Toronto, ON, Canada
Int J Radiat Oncol Biol Phys 79:459-65. 2011..To retrospectively review the results of a single-institution series of accelerated hypofractionated radiotherapy for early-stage non-small-cell lung cancer (NSCLC) in patients who are medically inoperable or who refuse surgery... - Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomyRichard Choo
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Eur Urol 52:1645-50. 2007..To examine the effect of postoperative radiotherapy (RT) plus 2-yr androgen suppression (AS) on quality of life (QOL) in patients with pathologic T3 or positive resection margins after radical prostatectomy (RP)... - Palliative thoracic radiotherapy for lung cancer: a systematic reviewAlysa Fairchild
Department of Radiation Oncology, Cross Cancer Institute, 11560 University Avenue, Edmonton, AB T6G 1Z2 Canada
J Clin Oncol 26:4001-11. 2008..The optimal dose of radiotherapy (RT) to palliate symptomatic advanced lung cancer is unclear. We systematically reviewed randomized controlled trials (RCTs) of palliative thoracic RT...